Suchergebnisse - "Leite de Oliveira, Rodrigo"

PubPharm (28)

1

Genetic and compound screens uncover factors modulating cancer cell response to indisulam

enthalten in: Life science alliance | 2022

von Pogacar, Z. | Groot, K. | Jochems, F. | +12

2

HISTONE DEACETYLASE INHIBITORS FOR USE IN THE TREATMENT OF DRUG RESISTANT MELANOMA

enthalten in: Europäisches Patentamt | 2022

von WANG LIQIN | LEITE DE OLIVEIRA RODRIGO | BERNARDS RENE

3

Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity

enthalten in: PloS one | 2022

von Pogacar, Z. | Johnson, J. | Krenning, L. | +15

4

Identification of Autophagy-Related Genes as Targets for Senescence Induction Using a Customizable CRISPR-Based Suicide Switch Screen

enthalten in: Molecular cancer research : MCR | 2021

von Schepers, A. | Jochems, F. | Lieftink, C. | +6

5

INTERFERING WITH MRNA SPLICING TO ENHANCE RESPONSE TO CHECKPOINT IMMUNOTHERAPIES.

enthalten in: Europäisches Patentamt | 2021

von BERNARDS RENÉ | LEITE DE OLIVEIRA RODRIGO

6

The Cancer SENESCopedia : A delineation of cancer cell senescence

enthalten in: Cell reports | 2021

von Jochems, F. | Thijssen, B. | De Conti, G. | +11

7

Histone deacetylase inhibitors for the use in the treatment of drug resistant melanoma

enthalten in: Europäisches Patentamt | 2020

von WANG LIQIN | LEITE DE OLIVEIRA RODRIGO | BERNARDS RENE

8

HISTONE DEACETYLASE INHIBITORS FOR THE USE IN THE TREATMENT OF DRUG RESISTANT MELANOMA

enthalten in: Europäisches Patentamt | 2018

von WANG LIQIN | LEITE DE OLIVEIRA RODRIGO | BERNARDS RENE

9

An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential

enthalten in: Cell | 2018

von Wang, L. | Leite de Oliveira, R. | Huijberts, S. | +12

CommentIn: Nat Rev Cancer. 2018 Jul;18(7):403. - PMID 29872113

10

Anti-cancer therapy : senescence is the new black

enthalten in: The EMBO journal | 2018

von Leite de Oliveira, R. | Bernards, R.

CommentOn: EMBO J. 2018 May 15;37(10):null. - PMID 29669860